The global takotsubo syndrome therapeutics market is predicted to exceed an impressive valuation of US$ 2.85 Billion in 2033, with a compound annual growth rate (CAGR) of 6.1% estimated from 2023 to 2033. In both industrialized and developing economies, cardiovascular diseases are the leading cause of death. The rising prevalence of cardiovascular problems such as …
Category Archives: Healthcare Trends
Peptide Drug Conjugates Market is projected to expand at a 20% CAGR through 2033
The global peptide drug conjugates market is anticipated to hold a market value of US$ 861.12 Million in 2023 and US$ 5,331.83 Million by 2033. The projected growth rate is nearly 20% during the forecast period from 2023 to 2033. The growth of the market is attributed to the global upsurge in cancer cases and …
Continue reading “Peptide Drug Conjugates Market is projected to expand at a 20% CAGR through 2033”
Chronic Wound Care Market is expected to expand at a 7% value CAGR by 2033
According to Future Market Insights, chronic wound care are expected to grow at a CAGR of 7% between 2023 and 2033, reaching US$ 31.46 Billion in 2033. Sales grew at a CAGR of 6.5% from 2018 to 2023. New innovative products are expected to be introduced to the market as a result of growing research …
Continue reading “Chronic Wound Care Market is expected to expand at a 7% value CAGR by 2033”
Pelvic Cancer Induced Hemorrhegic Cystitis Market is projected to reach US$ 11 Billion by 2033
The global pelvic cancer induced hemorrhegic cystitis market size is expected to surpass an impressive valuation of US$ 2.1 Billion in 2023 and is projected to reach US$ 11 Billion by 2033, with a CAGR of 18.01%, as per a recently published research by Future Market Insights. Rising awareness among the population regarding early treatment …
Vernal Keratoconjunctivitis Market is expected to grow with a 6% CAGR during 2023 to 2033
The global Vernal Keratoconjunctivitis market is expected to garner a market value of US$ 436.9 Million in 2023 and is expected to accumulate a market value of US$ 782.42 Million by registering a CAGR of 6% in the forecast period 2023 to 2033. One of the reasons driving the global market over the projection period …
Primary Sclerosing Cholangitis (PSC) Market is expected to flourish at a CAGR of 7.6% by 2033
The global market for Primary Sclerosing Cholangitis (PSC) is expected to be worth US$ 151.07 million in 2023. Because of rising alcohol consumption, the overall demand for Primary Sclerosing Cholangitis (PSC) is expected to grow at a CAGR of 7.6% between 2023 and 2033, totaling around US$ 314.26 Million by 2033. The Primary Sclerosing Cholangitis …
Hyperglycemia Treatment Market to grow at a 12.3% CAGR from 2023 to 2033, Insulin Therapy to be Most Common Treatment Approach: FMI Report
According to Future Market Insights, the global hyperglycemia treatment is expected to grow at a CAGR of 12.3% between 2023 and 2033, reaching US$ 1,596 Million in 2033. With the growing number of young people prone to stress levels and poor eating habits, hyperglycemia treatments have become more popular. According to a new study, COVID-19 …
Hyperammonemia Treatment Market to reach US$ 2,100 Million by 2033, glycerol phenylbutyrate to account for over 1/3rd of all Treatments: FMI
According to a recently published study by Future Market Insights, the global hyperammonemia treatment market size is expected to reach a valuation of US$ 1,318.05 Million in 2023 and is projected to reach US$ 2,100 Million by 2033, trailing a CAGR of 4.77%. The rising prevalence of urea cycle disorders and extensive research and development …
Research and Development for Hutchinson Gilford progeria syndrome (HGPS) Therapeutics to Register 8.5% CAGR: FMI Study
During the forecast period 2023-2033, the Hutchinson Gilford progeria syndrome (HGPS) Therapeutics market is expected to grow at a value of 8.5% CAGR, according to Future Market Insights. By the year 2033, the global market for Hutchinson Gilford progeria syndrome is expected to rise up to a market valuation of US$ 15,990 Million. Around 400 …
Intestinal Fistula Treatment Market Value to reach US$ 46.82 Billion by 2033; Proton-Pump Inhibitor Drugs to account for 45% of all Treatments: FMI Report
The global intestinal fistula treatment market is expected to be valued at US$ 26.64 Billion in 2023. With the continuous improvements in drugs and biotechnology, the overall demand for intestinal fistula treatment is projected to grow at a CAGR of 5.8% between 2023 and 2033, totaling around US$ 46.82 Billion by 2033. Factors such as …